Despite its utility, Ki-67 has several limitations. One major issue is inter-laboratory variability, as the assessment can be subjective and may vary depending on the laboratory and the specific antibodies used. Additionally, the Ki-67 index may not always correlate perfectly with clinical outcomes. Thus, it is often used in conjunction with other biomarkers and clinical factors to provide a more comprehensive picture of the tumor's behavior.
